Follow
Ali Saber
Title
Cited by
Cited by
Year
Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature
A Saber, TJN Hiltermann, K Kok, HJM Groen
Critical reviews in oncology/hematology 100, 107-116, 2016
1142016
The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
Y Liu, FR Abdul Razak, M Terpstra, FC Chan, A Saber, M Nijland, ...
Leukemia 28 (11), 2248-2251, 2014
1032014
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
B Liu, A Saber, HJ Haisma
Drug discovery today 24 (4), 955-970, 2019
772019
Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers
J Wei, AJ Van der Wekken, A Saber, MM Terpstra, E Schuuring, W Timens, ...
Cancers 10 (1), 10, 2018
402018
Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors
A Saber, TJN Hiltermann, K Kok, MM Terpstra, K de Lange, W Timens, ...
Carcinogenesis 38 (2), 144-151, 2017
392017
CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor
B Liu, S Song, R Setroikromo, S Chen, W Hu, D Chen, AJ van der Wekken, ...
Cancers 11 (4), 455, 2019
342019
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression
AJ van der Wekken, JL Kuiper, A Saber, MM Terpstra, J Wei, ...
PloS one 12 (8), e0182885, 2017
302017
Genomic aberrations guiding treatment of non-small cell lung cancer patients
A Saber, A van der Wekken, TJN Hiltermann, K Kok, A van den Berg, ...
Cancer Treatment Communications 4, 23-33, 2015
302015
Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: a review of the literature
M Karimpour, R Ravanbakhsh, M Maydanchi, A Rajabi, F Azizi, A Saber
Biomedicine & Pharmacotherapy 143, 112190, 2021
282021
CRISPR/Cas9 for overcoming drug resistance in solid tumors
A Saber, B Liu, P Ebrahimi, HJ Haisma
DARU Journal of Pharmaceutical Sciences 28, 295-304, 2020
282020
Copy number alterations assessed at the single-cell level revealed mono-and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient
P Ferronika, H Van Den Bos, A Taudt, DCJ Spierings, A Saber, ...
Annals of Oncology 28 (7), 1668-1670, 2017
252017
CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation
B Liu, OA Diaz Arguello, D Chen, S Chen, A Saber, HJ Haisma
Plos one 15 (5), e0232985, 2020
212020
Genomic aberrations in crizotinib resistant lung adenocarcinoma samples identified by transcriptome sequencing
A Saber, AJ van der Wekken, K Kok, MM Terpstra, LJ Bosman, MF Mastik, ...
PLoS One 11 (4), e0153065, 2016
212016
Transcriptional activation of cyclin D1 via HER2/HER3 contributes to EGFR-TKI resistance in lung cancer
B Liu, D Chen, S Chen, A Saber, H Haisma
Biochemical Pharmacology 178, 114095, 2020
172020
Moderate prognostic value of lncRNA FOXD2-AS1 in gastric cancer with Helicobacter pylori infection
A Rajabi, S Bastani, M Maydanchi, S Tayefeh-Gholami, S Abdolahi, ...
Journal of Gastrointestinal Cancer, 1-5, 2021
162021
Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
A Saber, AJ van der Wekken, GSMA Kerner, M van den Berge, W Timens, ...
PLoS One 11 (3), e0152317, 2016
142016
Prognostic value of lncRNA KRT18P55 in patients with intestinal type of gastric cancer
S Tayefeh-Gholami, M Ghanbari, A Aghazadeh, A Rajabi, A Saber, ...
Journal of Gastrointestinal Cancer, 1-6, 2021
92021
Anti-cancer effect of melatonin via downregulation of Delta-like ligand 4 in Estrogen-responsive breast cancer cells
A Rajabi, A Saber, M Pourmahdi, A Emami, R Ravanbakhsh, ...
Recent Patents on Anti-Cancer Drug Discovery 15 (4), 329-340, 2020
82020
An all-in-one transcriptome-based assay to identify therapy-guiding genomic aberrations in nonsmall cell lung cancer patients
J Wei, AA Rybczynska, P Meng, M Terpstra, A Saber, J Sietzema, ...
Cancers 12 (10), 2843, 2020
72020
Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells
M Pourmahdi, A Saber, A Rajabi, S Abdolahi, P Ebrahimi, ...
Curr. Stem Cell Res. Ther 16, 877-887, 2021
52021
The system can't perform the operation now. Try again later.
Articles 1–20